Data Insights
No Filter Selected
No Filter Selected
No Filter Selected
No Filter Selected
Adipose Tissue Derived Mesenchymal Stem Cells by CellTex Therapeutics for Coronavirus Disease 2019 (COVID-19): Likelihood of Approval
Adipose Tissue Derived Mesenchymal Stem Cells is under clinical development by CellTex Therapeutics and currently in Phase II for Coronavirus...
Stem Cell Therapy 2 for Coronavirus Disease 2019 (COVID-19) by CellTex Therapeutics for Coronavirus Disease 2019 (COVID-19): Likelihood of Approval
Stem Cell Therapy 2 for Coronavirus Disease 2019 (COVID-19) is under clinical development by CellTex Therapeutics and currently in Phase...
Mesenchymal Stem Cells-Derived Exosomes by CellTex Therapeutics for Alzheimer's Disease: Likelihood of Approval
Mesenchymal Stem Cells-Derived Exosomes is under clinical development by CellTex Therapeutics and currently in Phase I for Alzheimer's Disease. According...